Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
2.
J Med Chem ; 55(5): 2388-405, 2012 Mar 08.
Artículo en Inglés | MEDLINE | ID: mdl-22364337

RESUMEN

The discovery and characterization of compound 48, a selective and in vivo active mGlu2 receptor positive allosteric modulator (PAM), are described. A key to the discovery was the rational exploration of the initial HTS hit 13 guided by an overlay model built with reported mGlu2 receptor PAM chemotypes. The initial weak in vitro activity of the hit 13 was quickly improved, although compounds still had suboptimal druglike properties. Subsequent modulation of the physicochemical properties resulted in compounds having a more balanced profile, combining good potency and in vivo pharmacokinetic properties. Final refinement by addressing cardiovascular safety liabilities led to the discovery of compound 48. Besides good potency, selectivity, and ADME properties, compound 48 displayed robust in vivo activity in a sleep-wake electroencephalogram (sw-EEG) assay consistent with mGlu2 receptor activation, in accordance with previous work from our laboratories.


Asunto(s)
Nitrilos/síntesis química , Piridonas/síntesis química , Receptores de Glutamato Metabotrópico/agonistas , Regulación Alostérica , Animales , Encéfalo/metabolismo , Sinergismo Farmacológico , Canal de Potasio ERG1 , Electroencefalografía , Canales de Potasio Éter-A-Go-Go/fisiología , Células HEK293 , Humanos , Isomerismo , Ratones , Nitrilos/farmacocinética , Nitrilos/farmacología , Técnicas de Placa-Clamp , Piridonas/farmacocinética , Piridonas/farmacología , Ratas , Receptores de Glutamato Metabotrópico/metabolismo , Sueño REM/efectos de los fármacos , Relación Estructura-Actividad , Vigilia
3.
ACS Chem Neurosci ; 1(12): 788-95, 2010 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-22778815
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA